Lidocaine Maximum Strength Lidocaine LIDOCAINE LIDOCAINE DIHYDROXYALUMINUM AMINOACETATE ANHYDROUS CARBOXYMETHYLCELLULOSE SODIUM EDETATE DISODIUM GELATIN GLYCERIN KAOLIN PROPYLENE GLYCOL POLYSORBATE 80 POVIDONE SODIUM ACRYLATE TARTARIC ACID TITANIUM DIOXIDE Uses Temporarily relieves minor pain

Lidocaine Maximum Strength Lidocaine LIDOCAINE LIDOCAINE DIHYDROXYALUMINUM AMINOACETATE ANHYDROUS CARBOXYMETHYLCELLULOSE SODIUM EDETATE DISODIUM GELATIN GLYCERIN KAOLIN PROPYLENE GLYCOL POLYSORBATE 80 POVIDONE SODIUM ACRYLATE TARTARIC ACID TITANIUM DIOXIDE

Mfr: OTC
FunFoxMeds box

Drug Facts

Composition & Profile

Active Ingredients
Active ingredient Lidocaine 4%
Inactive Ingredients
Inactive Ingredients aluminum glycinate carboxymethylcellulose sodium EDTA disodium gelatin concentrate glycerin kaolin propylene glycol polysorbate 80 povidone sodium polyacrylate tartaric acid titanium oxide
Strengths
4 %
Treats Conditions
Uses Temporarily Relieves Minor Pain

Identifiers & Packaging

Container Type UNKNOWN
Packaging

Principal Display Panel †Compare to the active ingredient in Maximum Strength Aspercreme® Lidocaine Patch Maximum Strength Lidocaine Patch Lidocaine 4% Topical anesthetic fast acting numbs away pain desensitizes aggravted nerves no irritation and no burning odor-free †This product is not manufactured or distributed by Chattem, Inc., distributor of Maximum Strength Aspercreme® Lidocaine Patch. Manufactured by: TDS Pharm Co., Ltd. 12-13 Hanbul-ro 69beon-gil, Eumseong-eup, Eumseong, Chungbuk 27698 Republic of Korea www.tdspharm.com; Package Label Maximum Strength Lidocaine Patch Lidocaine 4%

Package Descriptions
  • Principal Display Panel †Compare to the active ingredient in Maximum Strength Aspercreme® Lidocaine Patch Maximum Strength Lidocaine Patch Lidocaine 4% Topical anesthetic fast acting numbs away pain desensitizes aggravted nerves no irritation and no burning odor-free †This product is not manufactured or distributed by Chattem, Inc., distributor of Maximum Strength Aspercreme® Lidocaine Patch. Manufactured by: TDS Pharm Co., Ltd. 12-13 Hanbul-ro 69beon-gil, Eumseong-eup, Eumseong, Chungbuk 27698 Republic of Korea www.tdspharm.com
  • Package Label Maximum Strength Lidocaine Patch Lidocaine 4%

Overview

Uses Temporarily relieves minor pain

Indications & Usage

Uses Temporarily relieves minor pain

Dosage & Administration

Directions Adults and children over 12 years: clean and dry affected area remove the transparent release liner (clear plastic backing) before application of patch to the skin apply immediately after removal from the protective envelope use 1 patch for up to 12 hours children 12 years or younger: ask a doctor

Warnings & Precautions
Warnings For external use only
Purpose

Purpose Topical Anesthetic

Do Not Use

Do Not Use more than 1 patch on your body at a time or on cut, irritated or swollen skin on puncture wounds for more than one week without consulting a doctor

When Using

When Using This Product use only as directed. Read and follow all directions and warnings on this label. do not allow contact with the eyes do not bandage tightly or apply local heat (such as heating pads) to the area of use do not use at the same time as other topical analgesics dispose of used patch in manner that always keeps product away from children or pets. Used patches still contain the drug product that can produce serious adverse effects if a child or pet chews or ingests this patch.

Stop Use & Ask a Doctor

Stop Use and Ask a Doctor if condition worsens redness is present irritation develops symptoms persist for more than 7 days or clear up and occur again within a few days you experience signs of skin injury, such as pain, swelling, or blistering where the product was applied

Keep Out of Reach of Children

Keep Out of Reach of Children If swallowed, get medical help or contact a Poison Control Center right away.

Questions

Questions or comments? Call 1-877-753-3935 Monday-Friday 9AM-5PM EST


Similar Drugs

Related medications based on brand, generic name, substance, active ingredients.

View all similar drugs →